Viewing Study NCT00353418


Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2025-12-26 @ 4:02 AM
Study NCT ID: NCT00353418
Status: COMPLETED
Last Update Posted: 2010-08-03
First Post: 2006-07-17
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection
Sponsor: Hoffmann-La Roche
Organization: